Feng Deng - 22 Jul 2021 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Reporting relationship: Director
Issuer ticker: CTKB
Reported as of: 22 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jul 2021, 20:57:18 UTC
Next SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Valerie Barnett, Attorney-in-Fact for Feng Deng

Key filing fact

Feng Deng filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 27 Jul 2021.

Key facts

This page summarizes Feng Deng's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 27 Jul 2021, 20:57.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTKB transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +147,933
Change %
Price
Shares after: 147,933
Date: 22 Jul 2021
Ownership: See footnote
Footnotes: F1, F2

CTKB transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +4,168,777
Change %
Price
Shares after: 4,168,777
Date: 22 Jul 2021
Ownership: See footnote
Footnotes: F1, F2

CTKB transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +443,800
Change %
Price
Shares after: 443,800
Date: 22 Jul 2021
Ownership: See footnote
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -147,933
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 147,933
Exercise price
Footnotes: F1, F2

CTKB transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -4,168,777
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 4,168,777
Exercise price
Footnotes: F1, F2

CTKB transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -443,800
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Jul 2021
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 443,800
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of Preferred Stock automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

Footnote F2

Shares held directly by Northern Light Venture Capital V, Ltd. ("NLVC V"). Fund V serves as the nominee for each of Northern Light Venture Fund V, L.P., Northern Light Strategic Fund V, L.P. and Northern Light Partners Fund V, L.P (together, the "NLVC V Funds"). Northern Light Partners V, L.P., a Cayman Islands exempted limited liability partnership, is the general partner of the NLVC V Funds. NLVC V is the general partner of Northern Light Partners V, L.P. Feng Deng is the controlling shareholder of NLVC V and may be deemed to have voting and dispositive power with respect to the shares held by NLVC V.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .